Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mismatch Repair01:20

Mismatch Repair

5.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.9K
Mismatch Repair01:36

Mismatch Repair

42.9K
Overview
42.9K
Mutations01:39

Mutations

92.3K
Overview
92.3K
Mutations01:35

Mutations

42.1K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
42.1K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

13.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current evidence and strategies for bridging therapy in CD19-directed chimeric antigen receptor T-cell therapy for relapsed/refractory large B-cell lymphomas.

Annals of hematology·2026
Same author

Genetic Subtype-Based International Prognostic Index Prognostic Model in Diffuse Large B-Cell Lymphoma.

MedComm·2025
Same author

Rapid Detection of Frogeye Leaf Spot Pathogen in Seeds by LAMP Assays to Protect Soybean Production.

Plant disease·2025
Same author

Development of Loop-Mediated Isothermal Amplification Assays for the Rapid and Accurate Diagnosis of <i>Exserohilum turcicum</i> for Field Applications.

Plant disease·2024
Same author

Prognostic value of circulating plasma cells detected by flow cytometry in newly diagnosed multiple myeloma patients: a systematic review and meta-analysis.

BMJ open·2024
Same author

Autologous stem cell transplant for refractory and relapsed peripheral T-cell lymphoma: a retrospective study in China.

Journal of Cancer·2024

Related Experiment Video

Updated: Nov 30, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.8K

Germline mutations and blood malignancy (Review).

Yuping Gong1, Jili Deng1, Xia Wu1

  • 1Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.

Oncology Reports
|November 17, 2020
PubMed
Summary

Germline mutations, present from birth, are key to inherited diseases and cancer predisposition. Understanding these genetic changes aids in identifying high-risk families and developing targeted therapies for better disease management.

Keywords:
germline mutationsomatic mutationcancer geneblood malignancyacute leukemiamyelodysplastic syndromes

More Related Videos

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

13.4K
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

4.3K

Related Experiment Videos

Last Updated: Nov 30, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.8K
Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

13.4K
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

4.3K

Area of Science:

  • Genetics
  • Molecular Biology
  • Oncology

Background:

  • Germline mutations originate in reproductive cells and affect all body cells, contrasting with somatic mutations acquired during life.
  • Clinical detection of germline mutations is crucial for identifying inherited cancer predispositions and at-risk families.
  • Somatic mutation detection aids in targeted drug discovery, tumor monitoring, and prognosis assessment.

Purpose of the Study:

  • To review the mechanisms underlying germline mutations in blood disorders.
  • To highlight the role of germline mutations in disease occurrence, development, and prognosis.
  • To discuss the limitations of traditional histopathology in cancer and the need for molecular-based approaches.

Main Methods:

  • Literature review of studies on germline mutations.
  • Analysis of large-scale population cohort data.
  • Exploration of integrated analysis from tumor research databases.

Main Results:

  • Germline mutations are strongly linked to disease incidence, progression, and outcomes.
  • Cancer-predisposition germline mutations can serve as indicators in high-risk populations.
  • Molecular heterogeneity within tumors necessitates advanced detection methods beyond traditional histopathology.

Conclusions:

  • Germline mutations play a significant role in the pathogenesis and clinical course of various diseases, particularly blood disorders.
  • Advanced molecular analyses, including integrated data from large projects, are essential for identifying novel tumor markers and therapeutic targets.
  • Understanding germline mutations is vital for personalized medicine, risk assessment, and the development of novel treatment strategies.